[177Lu]Lu-DOTA-TATE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [177Lu]Lu-DOTA-TATE, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab [Phase 1, Phase 2]